|
VRTX | Vertex Pharmaceuticals Inc / Ma |
|
|
VRTX | Vertex Pharmaceuticals Inc / Ma |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 0.47 |
| Leverage | 27.10% |
| Market Cap | $ 120.6B |
| PE | 27.88 |
| Dividend Yield | 0.00% |
| Profit | $ 4.3B |
| Margin | 35.47% |
Vertex Pharmaceuticals, Inc. is an American biopharmaceutical company based in Boston, Massachusetts.